1
|
Sun YW, Cen YH, Chen MH, Yan XK, Jin XF. Safety profiles and adverse reactions of azithromycin in the treatment of pediatric respiratory diseases: A systematic review and meta-analysis. Medicine (Baltimore) 2023; 102:e36306. [PMID: 38050289 PMCID: PMC10695561 DOI: 10.1097/md.0000000000036306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/01/2023] [Accepted: 11/03/2023] [Indexed: 12/06/2023] Open
Abstract
BACKGROUND Azithromycin (AZM) is an antimicrobial agent and frequently used in the treatment of pediatric respiratory diseases due to its well-recognized clinical efficacy. Despite some favorable findings from many studies, there is a lack of research reports focusing on the safety profiles and adverse reactions. METHODS The randomized controlled trials of AZM in the treatment of pediatric respiratory diseases on internet databases were searched. The search databases included Chinese CNKI, Wanfang, VIP, PubMed, EMBASE, and Cochrane Library. Two researchers of this study independently assessed the eligibility, risk of bias, and extracted the data. The included literature was meta-analyzed and subgroup analyzed by revman 5.1 software. RESULTS A total of 14 eligible studies were included. The results of meta-analysis showed that the incidence of adverse reactions after AZM treatment was 24.20%, which was lower than 48.05% in the control group (OR = 0.42, 95% CI 0.12-0.72, P < .001). In the subgroup of sequential therapy, AZM had a lower incidence of adverse reactions in sequential therapy (OR = 0.29, 95% CI 0.09-0.60, P < .001). In the subgroup of intravenous administration, AZM had a lower the incidence of adverse reactions (OR = 0.57, 95% CI 0.12-0.84, P = .003). In the subgroup of oral administration, AZM had a lower the incidence of adverse reactions (OR = 0.45, 95% CI 0.13-0.69 P < .001). Overall, it was also found that the incidence of adverse reactions in the AZM subgroup was significantly lower than that in other treatment subgroup. CONCLUSION AZM has fewer adverse reactions and better safety profiles, which make AZM a more attractive option in the treatment of pediatric respiratory diseases.
Collapse
Affiliation(s)
- Ying-wen Sun
- Department of Pediatrics, The People’s Hospital of Fenghua, Ningbo City, Zhejiang Province, China
| | - Yuan-hua Cen
- Department of Pediatrics, The People’s Hospital of Fenghua, Ningbo City, Zhejiang Province, China
| | - Mu-heng Chen
- Department of Pediatrics, The People’s Hospital of Fenghua, Ningbo City, Zhejiang Province, China
| | - Xu-ke Yan
- Department of Pediatrics, The People’s Hospital of Fenghua, Ningbo City, Zhejiang Province, China
| | - Xiao-fen Jin
- Department of Pediatrics, The People’s Hospital of Fenghua, Ningbo City, Zhejiang Province, China
| |
Collapse
|
2
|
Middleton J, Colthart G, Dem F, Elkins A, Fairhead J, Hazell RJ, Head MG, Inacio J, Jimbudo M, Jones CI, Laman M, MacGregor H, Novotny V, Peck M, Philip J, Paliau J, Pomat W, Stockdale JA, Sui S, Stewart AJ, Umari R, Walker SL, Cassell JA. Health service needs and perspectives of a rainforest conserving community in Papua New Guinea's Ramu lowlands: a combined clinical and rapid anthropological assessment with parallel treatment of urgent cases. BMJ Open 2023; 13:e075946. [PMID: 37802618 PMCID: PMC10565268 DOI: 10.1136/bmjopen-2023-075946] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/23/2023] [Accepted: 08/31/2023] [Indexed: 10/10/2023] Open
Abstract
OBJECTIVES Determine community needs and perspectives as part of planning health service incorporation into Wanang Conservation Area, in support of locally driven sustainable development. DESIGN Clinical and rapid anthropological assessment (individual primary care assessments, key informant (KI) interviews, focus groups (FGs), ethnography) with treatment of urgent cases. SETTING Wanang (pop. c189), a rainforest community in Madang province, Papua New Guinea. PARTICIPANTS 129 villagers provided medical histories (54 females (f), 75 males (m); median 19 years, range 1 month to 73 years), 113 had clinical assessments (51f, 62m; median 18 years, range 1 month to 73 years). 26 ≥18 years participated in sex-stratified and age-stratified FGs (f<40 years; m<40 years; f>40 years; m>40 years). Five KIs were interviewed (1f, 4m). Daily ethnographic fieldnotes were recorded. RESULTS Of 113 examined, 11 were 'well' (a clinical impression based on declarations of no current illness, medical histories, conversation, no observed disease signs), 62 (30f, 32m) were treated urgently, 31 referred (15f, 16m), indicating considerable unmet need. FGs top-4 ranked health issues concorded with KI views, medical histories and clinical examinations. For example, ethnoclassifications of three ((A) 'malaria', (B) 'sotwin', (C) 'grile') translated to the five biomedical conditions diagnosed most ((A) malaria, 9 villagers; (B) upper respiratory infection, 25; lower respiratory infection, 10; tuberculosis, 9; (C) tinea imbricata, 15) and were highly represented in declared medical histories ((A) 75 participants, (B) 23, (C) 35). However, 29.2% of diagnoses (49/168) were limited to one or two people. Treatment approaches included plant medicines, stored pharmaceuticals, occasionally rituals. Travel to hospital/pharmacy was sometimes undertaken for severe/refractory disease. Service barriers included: no health patrols/accessible aid post, remote hospital, unfamiliarity with institutions and medicine costs. Service introduction priorities were: aid post, vaccinations, transport, perinatal/birth care and family planning. CONCLUSIONS This study enabled service planning and demonstrated a need sufficient to acquire funding to establish primary care. In doing so, it aided Wanang's community to develop sustainably, without sacrificing their forest home.
Collapse
Affiliation(s)
- Jo Middleton
- Department of Primary Care and Public Health, Brighton and Sussex Medical School, Watson Building, University of Brighton, Falmer, UK
| | - Gavin Colthart
- Department of Primary Care and Public Health, Brighton and Sussex Medical School, Watson Building, University of Brighton, Falmer, UK
| | - Francesca Dem
- New Guinea Binatang Research Centre, Madang, Papua New Guinea
| | - Alice Elkins
- Department of Ecology and Evolution, University of Sussex, Falmer, UK
| | - James Fairhead
- Department of Anthropology, University of Sussex, Falmer, UK
| | - Richard J Hazell
- Department of Ecology and Evolution, University of Sussex, Falmer, UK
| | - Michael G Head
- Clinical Informatics Research Unit, Faculty of Medicine, University of Southampton, Southampton, UK
| | - Joao Inacio
- School of Applied Sciences, Cockcroft Building, University of Brighton, Brighton, UK
| | - Mavis Jimbudo
- New Guinea Binatang Research Centre, Madang, Papua New Guinea
| | - Christopher Iain Jones
- Medical Statistics, Brighton and Sussex Medical School, Watson Building, University of Brighton, Falmer, UK
| | - Moses Laman
- Papua New Guinea Institute of Medical Research, Port Moresby, Papua New Guinea
| | - Hayley MacGregor
- Health and Nutrition Research Cluster, Institute of Development Studies, Falmer, UK
| | - Vojtech Novotny
- Department of Zoology, Faculty of Science, University of South Bohemia in Ceske Budejovice, Ceske Budejovice, Czech Republic
- Institute of Entomology, Biology Centre, Czech Academy of Sciences, Ceske Budejovice, Czech Republic
| | - Mika Peck
- Department of Ecology and Evolution, University of Sussex, Falmer, UK
| | - Jonah Philip
- New Guinea Binatang Research Centre, Madang, Papua New Guinea
- Wanang Conservation Area, Wanang, Papua New Guinea
| | - Jason Paliau
- New Guinea Binatang Research Centre, Madang, Papua New Guinea
- Department of Environmental Engineering & Renewable Energy, School of Environment and Climate Change, Papua New Guinea University of Natural Resources and Environment, Kokopo, Papua New Guinea
| | - William Pomat
- PNG Institute of Medical Research, Goroka, Papua New Guinea
| | - Jessica A Stockdale
- Department of Primary Care and Public Health, Brighton and Sussex Medical School, Watson Building, University of Brighton, Falmer, UK
| | - Shen Sui
- New Guinea Binatang Research Centre, Madang, Papua New Guinea
| | - Alan J Stewart
- Department of Ecology and Evolution, University of Sussex, Falmer, UK
| | - Ruma Umari
- New Guinea Binatang Research Centre, Madang, Papua New Guinea
- Wanang Conservation Area, Wanang, Papua New Guinea
| | - Stephen L Walker
- Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK
- Hospital for Tropical Diseases, and Department of Dermatology, University College London Hospitals NHS Foundation Trust, London, UK
| | - Jackie A Cassell
- Department of Primary Care and Public Health, Brighton and Sussex Medical School, Watson Building, University of Brighton, Falmer, UK
| |
Collapse
|
3
|
Dah C, Ourohire M, Sié A, Ouédraogo M, Bountogo M, Boudo V, Lebas E, Nyatigo F, Arnold BF, O'Brien KS, Oldenburg CE. How does baseline anthropometry affect anthropometric outcomes in children receiving treatment for severe acute malnutrition? A secondary analysis of a randomized controlled trial. MATERNAL & CHILD NUTRITION 2022; 18:e13329. [PMID: 35157777 PMCID: PMC9218313 DOI: 10.1111/mcn.13329] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/28/2021] [Revised: 01/20/2022] [Accepted: 01/21/2022] [Indexed: 11/01/2022]
Abstract
Mid-upper arm circumference (MUAC) < 11.5 cm and weight-for-height Z-score (WHZ) < -3 are used for screening for severe acute malnutrition (SAM). Underweight and concurrent wasting and stunting may better target those at the highest risk of mortality. We compared anthropometric outcomes in children enrolled in a trial of antibiotics for SAM based on categories of baseline anthropometry, including indicators for programme admission (WHZ < -3, MUAC < 11.5) and alternative indicators (weight-for-age Z-score [WAZ] < -3, concurrent wasting and stunting [WHZ < -3 and height-for-age Z-score < -3]). Participants were followed weekly until nutritional recovery and at 8 weeks. We evaluated changes in weight gain (g/kg/day), MUAC, and WHZ in children admitted by admissions criteria (MUAC only, WHZ only, or MUAC and WHZ) and by underweight or concurrent wasting and stunting. Of 301 admitted children, 100 (33%) were admitted based on MUAC only, 41 (14%) WHZ only, and 160 (53%) both MUAC and WHZ, 210 (68%) were underweight and 67 (22%) were concurrently wasted/stunted. Low MUAC and low WHZ children had the lowest probability of nutritional recovery (17% vs. 50% for MUAC-only and 34% for WHZ-only). There was no difference in weight gain velocity or WHZ by admissions criteria (WHZ and/or MUAC). Underweight and concurrently wasted/stunted children had lower MUAC and WHZ at 8 weeks compared with those who were not underweight or concurrently wasted and stunted. Children with both low MUAC and low WHZ had the worst outcomes. Relying on MUAC alone may miss children who have poor outcomes. Other indicators, such as WAZ, may be useful for identifying vulnerable children.
Collapse
Affiliation(s)
- Clarisse Dah
- Centre de Recherche en Santé de NounaNounaBurkina Faso
| | | | - Ali Sié
- Centre de Recherche en Santé de NounaNounaBurkina Faso
| | | | | | | | - Elodie Lebas
- Francis I Proctor FoundationUniversity of CaliforniaSan FranciscoCaliforniaUSA
| | - Fanice Nyatigo
- Francis I Proctor FoundationUniversity of CaliforniaSan FranciscoCaliforniaUSA
| | - Benjamin F. Arnold
- Francis I Proctor FoundationUniversity of CaliforniaSan FranciscoCaliforniaUSA
- Department of OphthalmologyUniversity of CaliforniaSan FranciscoCaliforniaUSA
| | - Kieran S. O'Brien
- Francis I Proctor FoundationUniversity of CaliforniaSan FranciscoCaliforniaUSA
| | - Catherine E. Oldenburg
- Francis I Proctor FoundationUniversity of CaliforniaSan FranciscoCaliforniaUSA
- Department of OphthalmologyUniversity of CaliforniaSan FranciscoCaliforniaUSA
- Department of Epidemiology & BiostatisticsUniversity of CaliforniaSan FranciscoCaliforniaUSA
| |
Collapse
|
4
|
O’Brien KS, Sié A, Dah C, Ourohiré M, Ouedraogo M, Boudo V, Arzika A, Lebas E, Nyatigo F, Godwin W, Kelly JD, Arnold BF, Oldenburg CE. Comparing Azithromycin to Amoxicillin in the Management of Uncomplicated Severe Acute Malnutrition in Burkina Faso: A Pilot Randomized Trial. Am J Trop Med Hyg 2022; 106:930-938. [PMID: 35008055 PMCID: PMC8922483 DOI: 10.4269/ajtmh.21-1023] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2021] [Accepted: 11/12/2021] [Indexed: 11/07/2022] Open
Abstract
Azithromycin is a promising alternative to amoxicillin in the management of uncomplicated severe acute malnutrition (SAM) as it can be administered as a single dose and has efficacy against several pathogens causing infectious disease and mortality in children under 5. In this pilot trial, we aimed to establish the feasibility of a larger randomized controlled trial and provide preliminary evidence comparing the effect of azithromycin to amoxicillin on weight gain in children with uncomplicated SAM. We enrolled children 6-59 months old with uncomplicated SAM at six healthcare centers in Burkina Faso. Participants were randomized to a single dose of azithromycin or a 7-day course of amoxicillin and followed weekly until nutritional recovery and again at 8 weeks. Apart from antibiotics, participants received standard of care, which includes ready-to-use therapeutic food. Primary feasibility outcomes included enrollment potential, refusals, and loss to follow-up. The primary clinical outcome was weight gain (g/kg/day) over 8 weeks. Outcome assessors were masked. Between June and October 2020, 312 children were screened, 301 were enrolled with zero refusals, and 282 (93.6%) completed the 8-week visit. Average weight gain was 2.5 g/kg/day (standard deviation [SD] 2.0) in the azithromycin group and 2.6 (SD 1.7) in the amoxicillin group (mean difference -0.1, 95% CI -0.5 to 0.3, P = 0.63). Fewer adverse events were reported in the azithromycin group (risk ratio 0.50, 95% CI 0.31-0.82, P = 0.006). With strong enrollment and follow-up, a fully powered trial in this setting is feasible.
Collapse
Affiliation(s)
- Kieran S. O’Brien
- Francis I Proctor Foundation, University of California, San Francisco, California
| | - Ali Sié
- Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso
| | - Clarisse Dah
- Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso
| | | | | | - Valentin Boudo
- Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso
| | - Ahmed Arzika
- Centre de Recherche et Interventions en Santé Publique, Niamey, Niger
| | - Elodie Lebas
- Francis I Proctor Foundation, University of California, San Francisco, California
| | - Fanice Nyatigo
- Francis I Proctor Foundation, University of California, San Francisco, California
| | - William Godwin
- Francis I Proctor Foundation, University of California, San Francisco, California
| | - J. Daniel Kelly
- Francis I Proctor Foundation, University of California, San Francisco, California
| | - Benjamin F. Arnold
- Francis I Proctor Foundation, University of California, San Francisco, California;,Department of Ophthalmology, University of California, San Francisco, California
| | - Catherine E. Oldenburg
- Francis I Proctor Foundation, University of California, San Francisco, California;,Department of Ophthalmology, University of California, San Francisco, California;,Department of Epidemiology & Biostatistics, University of California, San Francisco, California,Address correspondence to Catherine E. Oldenburg, Francis I. Proctor Foundation, University of California, San Francisco, 490 Illinois St., 2nd floor, San Francisco, CA 94158. E-mail:
| |
Collapse
|